Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2022-11-23 00:00:00 ET · period of report 2022-11-21 · accession 0001209191-22-058595 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-23 | 2022-11-21 | DLB | Couling John D | SVP, Entertainment | S - Sale | $69.02 | -40 | 79.2K | -0.1% | -$2,761 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-11-21 | S | D | 40 | $69.02 | 79,195 | D | — | — | (F1) Shares held following the reported transactions include 35,653 restricted stock units, which are subject to forfeiture until they vest. (F2) Shares include 38 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2022. |